AMSBIO (Oxford, UK) has announced RPMotion, a spinning organoid bioreactor that facilitates fast, easy and efficient organoid culture for drug discovery, disease modeling and regenerative medicine.

WuXi Biologics, a CRDMO, reports that three sets of 5,000L single-use bioreactors have been installed in the second drug substance line at its drug substance manufacturing facility in Hangzhou (MFG20) ...

In a recent effort to scale up the manufacturing of platelets using iPS cell-derived megakaryocytes, Professor Koji Eto (Department of Clinical Application) and his team of researchers, through ...

cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields The disruptive, proprietary technology developed by EVerZom offers a ...